Insider Selling: MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Sells 24,000 Shares of Stock

MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Richard Giroux sold 24,000 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $6.29, for a total value of $150,960.00. Following the sale, the chief financial officer now owns 849,947 shares of the company’s stock, valued at $5,346,166.63. The trade was a 2.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

MeiraGTx Stock Up 2.4 %

Shares of MeiraGTx stock traded up $0.15 during trading on Tuesday, hitting $6.41. 400,666 shares of the stock traded hands, compared to its average volume of 327,372. The stock has a market cap of $500.96 million, a P/E ratio of -5.30, a PEG ratio of 0.34 and a beta of 1.26. The company has a debt-to-equity ratio of 0.86, a quick ratio of 2.34 and a current ratio of 2.34. MeiraGTx Holdings plc has a twelve month low of $3.85 and a twelve month high of $7.37. The company has a fifty day moving average price of $6.21 and a two-hundred day moving average price of $5.25.

Institutional Investors Weigh In On MeiraGTx

Several institutional investors have recently made changes to their positions in the company. Rhumbline Advisers lifted its holdings in MeiraGTx by 10.8% in the 2nd quarter. Rhumbline Advisers now owns 52,996 shares of the company’s stock worth $223,000 after purchasing an additional 5,178 shares during the last quarter. American Century Companies Inc. lifted its holdings in MeiraGTx by 42.4% in the 2nd quarter. American Century Companies Inc. now owns 40,008 shares of the company’s stock worth $168,000 after purchasing an additional 11,907 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in MeiraGTx by 14.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 462,950 shares of the company’s stock worth $1,949,000 after purchasing an additional 58,854 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in MeiraGTx by 100.9% in the 2nd quarter. Hsbc Holdings PLC now owns 23,954 shares of the company’s stock worth $102,000 after purchasing an additional 12,029 shares during the last quarter. Finally, Squarepoint Ops LLC acquired a new position in MeiraGTx during the 2nd quarter worth $123,000. 67.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on MGTX. Chardan Capital reissued a “buy” rating and set a $36.00 target price on shares of MeiraGTx in a research note on Monday, November 18th. Royal Bank of Canada lifted their target price on shares of MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.